SCHEMBL3414951

SCHEMBL3414951

O=C(O)c1cccc(-c2ccc(Cl)c(CNC(=O)c3ccc(Cl)cc3Cl)c2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 3/20 0.58
PPARG P37231 2/20 0.58
ACLY P53396 1/20 0.57
EPHX2 P34913 2/20 0.50
FLT1 P17948 2/20 0.48
FLT4 P35916 2/20 0.48
KDR P35968 2/20 0.48
DCLRE1B Q9H816 1/20 0.48
HPGD P15428 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
PPARD Q03181 2/20 0.46
RXRA P19793 1/20 0.46
RXRB P28702 1/20 0.46
MRGPRX4 Q96LA9 1/20 0.46
POLB P06746 2/20 0.45
THRB P10828 1/20 0.45
RECQL P46063 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
SERPINE1 P05121 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3414230 0.87 PPARA (0.63) PPARAPPARGACLYEPHX2PPARD
SCHEMBL3419208 0.86 PPARG (0.57) PPARAPPARGACLYEPHX2HPGD
SCHEMBL3418691 0.86 PPARD (0.56) PPARAPPARGACLYEPHX2HPGD
SCHEMBL3417095 0.85 PPARD (0.51) PPARAPPARGACLYEPHX2DCLRE1B
SCHEMBL3417151 0.84 PPARD (0.61) PPARAPPARGACLYPPARDMAPT
SCHEMBL13460889 0.83 HPGD (0.47) PPARAPPARGACLYFLT1FLT4
SCHEMBL3416610 0.83 PPARD (0.53) PPARAPPARGACLYEPHX2PPARD
SCHEMBL3414382 0.83 ACLY (0.55) PPARAPPARGACLYEPHX2FLT1
SCHEMBL3413844 0.81 HPGD (0.61) PPARAPPARGACLYFLT1FLT4
SCHEMBL13433330 0.81 PPARA (0.46) PPARAPPARGACLYEPHX2FLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7687664-B2 Carboxylic acid derivative, a salt thereof or an ester of them, and medicament comprising it EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-03-30 US disclosed
US-7687664-B2 Carboxylic acid derivative, a salt thereof or an ester of them, and medicament comprising it EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-03-30 US disclosed
US-20040214888-A1 Carboxylic acid derivative and medicine comprising salt or ester of the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-10-28 US disclosed
EP-1394147-A1 CARBOXYLIC ACID DERIVATIVE AND MEDICINE COMPRISING SALT OR ESTER OF THE SAME Eisai Co., Ltd. (JP) 2004-03-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040214888-A1 Carboxylic acid derivative and medicine comprising salt or ester of the same GPR119, NR3C1, INSR PPARA 130/4885PPARG 238/4885ACLY 354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.